Last news
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Notified -...

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

Notified -...

Sagtec Expands AI SaaS Monetization Strategy as Enterprise Pipeline Scales; Company Advances Toward AI-Native Recurring Revenue Model

Sagtec Expands AI SaaS Monetization Strategy as Enterprise Pipeline Scales; Company Advances Toward AI-Native Recurring Revenue Model

Notified -...

Salsify Powers AI-Driven Commerce at Enterprise Scale, Accelerating Customer Automation and Growth

Salsify Powers AI-Driven Commerce at Enterprise Scale, Accelerating Customer Automation and Growth

Notified -...

Coventry Announces Expanded Relationship with NAIFA

Coventry Announces Expanded Relationship with NAIFA

Notified -...

NBIM Signs Partnership with Credit Benchmark to Strengthen Insight into Unrated Counterparty Risk

NBIM Signs Partnership with Credit Benchmark to Strengthen Insight into Unrated Counterparty Risk

Notified -...

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025

Notified -...

Telefónica and Mavenir Forge Strategic Partnership to Accelerate AI Innovation in Telecom

Telefónica and Mavenir Forge Strategic Partnership to Accelerate AI Innovation in Telecom

Notified -...

1 ... 47 48 49 50 51 52 53 54 55 ... 1061
menu
menu